AU8675098A - Screening assays for g protein coupled receptor agonists and antagonists - Google Patents

Screening assays for g protein coupled receptor agonists and antagonists

Info

Publication number
AU8675098A
AU8675098A AU86750/98A AU8675098A AU8675098A AU 8675098 A AU8675098 A AU 8675098A AU 86750/98 A AU86750/98 A AU 86750/98A AU 8675098 A AU8675098 A AU 8675098A AU 8675098 A AU8675098 A AU 8675098A
Authority
AU
Australia
Prior art keywords
protein coupled
coupled receptor
antagonists
pthr
receptor agonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU86750/98A
Other languages
English (en)
Inventor
F. Richard Bringhurst
Hisashi Takasu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp filed Critical General Hospital Corp
Publication of AU8675098A publication Critical patent/AU8675098A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Endocrinology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU86750/98A 1997-07-31 1998-07-30 Screening assays for g protein coupled receptor agonists and antagonists Abandoned AU8675098A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08903977 1997-07-31
US08/903,977 US6183974B1 (en) 1997-07-31 1997-07-31 Screening assays for G protein coupled receptor agonists and antagonists
PCT/US1998/015877 WO1999006535A1 (en) 1997-07-31 1998-07-30 Screening assays for g protein coupled receptor agonists and antagonists

Publications (1)

Publication Number Publication Date
AU8675098A true AU8675098A (en) 1999-02-22

Family

ID=25418329

Family Applications (1)

Application Number Title Priority Date Filing Date
AU86750/98A Abandoned AU8675098A (en) 1997-07-31 1998-07-30 Screening assays for g protein coupled receptor agonists and antagonists

Country Status (8)

Country Link
US (2) US6183974B1 (https=)
EP (1) EP1012241B1 (https=)
JP (1) JP4261766B2 (https=)
AT (1) ATE291615T1 (https=)
AU (1) AU8675098A (https=)
DE (1) DE69829483T2 (https=)
ES (1) ES2239398T3 (https=)
WO (1) WO1999006535A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4486256B2 (ja) * 1998-10-22 2010-06-23 ザ・ジェネラル・ホスピタル・コーポレイション 副甲状腺ホルモン（ＰＴＨ）および副甲状腺ホルモン関連ペプチド（ＰＴＨｒＰ）の生物活性ペプチドおよびペプチド誘導体
WO2001023521A2 (en) * 1999-09-29 2001-04-05 The General Hospital Corporation Polypeptide derivatives of parathyroid hormone (pth)
US6756480B2 (en) 2000-04-27 2004-06-29 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
AU2002339843B2 (en) * 2001-07-23 2007-12-06 The General Hospital Corporation Conformationally constrained parathyroid hormone (PTH) analogs
US7166463B2 (en) * 2001-11-16 2007-01-23 The Regents Of The University Of Colorado Nucleic acids encoding modified olfactory cyclic nucleotide gated ion channels
US7795220B2 (en) * 2003-03-19 2010-09-14 The General Hospital Corporation Conformationally constrained parathyroid hormones with alpha-helix stabilizers
JP4871128B2 (ja) * 2003-07-17 2012-02-08 ザ ジェネラル ホスピタル コーポレイション 高次構造的に制約された副甲状腺ホルモン（ｐｔｈ）アナログ
DOP2006000008A (es) * 2005-01-10 2006-08-31 Arena Pharm Inc Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1
US7833730B2 (en) * 2006-04-11 2010-11-16 Arena Pharmaceuticals, Inc. Methods of using GPR119 to identify compounds useful for increasing bone mass in an individual
PE20071221A1 (es) 2006-04-11 2007-12-14 Arena Pharm Inc Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas
WO2008019062A2 (en) * 2006-08-04 2008-02-14 The General Hospital Corporation Polypeptide derivatives of parathyroid hormone (pth)
EP1961765A1 (en) * 2006-12-08 2008-08-27 Zealand Pharma A/S Truncated PTH peptides with a cyclic conformation
CN104072606B (zh) * 2007-08-01 2017-09-22 总医院有限公司 利用g蛋白偶联受体和相关组合物的筛选方法
EP2108960A1 (en) 2008-04-07 2009-10-14 Arena Pharmaceuticals, Inc. Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditons modulated by PYY
MX358161B (es) 2010-05-13 2018-08-06 The General Hospital Corp Star Analogos de hormona paratiroidea y usos para los mismos.
JP6093946B2 (ja) * 2014-02-25 2017-03-15 国立大学法人東北大学 Ｇタンパク質共役型受容体のシグナル伝達の検出方法
US11975050B2 (en) 2018-03-16 2024-05-07 The General Hospital Corporation Parathyroid hormone polypeptide conjugates and methods of their use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5462856A (en) 1990-07-19 1995-10-31 Bunsen Rush Laboratories, Inc. Methods for identifying chemicals that act as agonists or antagonists for receptors and other proteins involved in signal transduction via pathways that utilize G-proteins
DE69233472T2 (de) * 1991-04-05 2006-02-09 The General Hospital Corp., Charlestown Parathormonrezeptor und dafür codierende DNA
DE4138621A1 (de) 1991-11-25 1993-06-17 Boehringer Ingelheim Int Verfahren zum screenen von substanzen mit modulierender wirkung auf einen rezeptorabhaengigen zellulaeren signaluebertragungsweg

Also Published As

Publication number Publication date
JP4261766B2 (ja) 2009-04-30
DE69829483D1 (de) 2005-04-28
US6183974B1 (en) 2001-02-06
US7033773B1 (en) 2006-04-25
ATE291615T1 (de) 2005-04-15
WO1999006535A1 (en) 1999-02-11
JP2001512664A (ja) 2001-08-28
EP1012241B1 (en) 2005-03-23
DE69829483T2 (de) 2006-04-27
EP1012241A1 (en) 2000-06-28
ES2239398T3 (es) 2005-09-16
EP1012241A4 (en) 2001-10-10

Similar Documents

Publication Publication Date Title
AU8675098A (en) Screening assays for g protein coupled receptor agonists and antagonists
AU1663092A (en) Receptor-based screening methods for amylin agonists and antagonists
AU4593097A (en) Methods and compositions for identifying receptor effectors
DE69901714D1 (de) Elektrochemischer affinitätsassay
WO2000031261A3 (en) Methods and compositions for identifying effectors of the formyl peptide receptor like-1 (fprl-1) receptor
CA2305810A1 (en) Methods of assaying receptor activity and constructs useful in such methods
AU8988098A (en) Vectors derived from antibodies for transferring substances into cells
SG149693A1 (en) Peptides acting as both glp-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
WO1998010068A3 (en) Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
AU1208497A (en) Ligand polypeptides for the g-protein-coupled receptor protein, their production and use
WO1998051329A1 (en) Cachexia remedy
EP1029916A4 (en) HUMAN LYSOPHOSPHATIDE ACID RECEPTOR AND USE OF SAID RECEPTOR
DE69738072D1 (de) Modifizierte steroid-hormon rezeptoren
AR010041A1 (es) Agonistas multifuncionales quimericos de receptores de hematopoyetina
BR9903862A (pt) Uso de carboxilatos e sulfonatos metálicos como agentes de controle de carga
EP0830600A4 (en) FUNCTIONAL BIOLOGICAL ASSAY FOR AGONIST AND ANTAGONIST OF PROTEIN G COUPLED RECEPTORS
AU2000273414A1 (en) Enzyme-based gprotein-coupled receptor assay
PT979410E (pt) Metodo para a determinacao da activacao de receptor para citocina pelo uso de umanticorpo
FR2762602B1 (fr) Moyens pour la detection precoce de pathologies auto-immunes inflammatoires
AU3757999A (en) Adenosine a1 receptor antagonist containing composition and method for restoringdiuretic and renal function
WO1998050546A3 (en) B cell receptor associated proteins
ATE307888T1 (de) Transporterproteine spezifisch für schilddrüsenhormone und deren agonisten und antagonisten
EP1286165A3 (en) Neuropeptide receptor and uses thereof
WO2002014466A3 (en) Pth analogs for renal osteodystrophy and related uses

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase